Table 1.
Recurrent VTE and major bleeding event rates in cancer patients enrolled in the RECOVER, EINSTEIN-DVT, EINSTEIN-PE, AMPLIFY, and Hokusai trials33-36
*Active cancer defined as having metastatic disease, recurrent cancer, or having been diagnosed or received treatment for cancer within 5 years prior to study enrollment.
†Active cancer was not defined.
‡Active cancer defined as having metastatic disease, recurrent cancer, or having been diagnosed or received treatment for cancer within 6 months prior to study enrollment.
§Active Cancer was defined according to the discretion of the local investigator.
